InsiderTrades

Form 4 for TVTX Travere Therapeutics, Inc.

Accepted 2025-02-12 00:00:00 ET · period of report 2025-02-10 · accession 0001415889-25-003821 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-02-12 2025-02-10 TVTX Heerma Peter Chief COMMERCIAL Off M - OptEx — +8,000 130.7K +7% —
DM 2025-02-12 2025-02-11+ TVTX Heerma Peter Chief COMMERCIAL Off S - Sale+OE $24.33 -5,642 127.6K -4% -$137.3K
D 2025-02-12 2025-02-10 TVTX Heerma Peter Chief COMMERCIAL Off M - OptEx $0.00 -8,000 0 -100% $0

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-02-10 M A 8,000 — 130,708 D — — (F2) Each PSU represents a contingent right to receive one share of the common stock of the Issuer.
2 Common Common Stock 2025-02-12 S D 2,568 $23.53 125,066 D — — (F4) Represents the number of shares required to be sold by the Reporting Person to cover the tax withholding obligation in connection with the settlement of vested PSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the Reporting Person to fund this tax withholding obligation by completing a "sell to cover" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the Reporting Person.
3 Common Common Stock 2025-02-11 S D 3,074 $25.00 127,634 D — —
4 Derivative Performance-based restricted stock units 2025-02-10 M D 8,000 $0.00 0 D — · — to — 8,000 Common Stock (F2) Each PSU represents a contingent right to receive one share of the common stock of the Issuer.